Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (81-90 of 429) with videos related to

Pageof 43
Sort By:
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
JCO Oncology Practice|October 15, 2021
Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 PandemicKelsey E Breen, Malwina Tuman, Corinna E Bertelsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
BRCA mutations and risk of prostate cancer in Ashkenazi JewsTomas Kirchhoff, Noah D Kauff, Nandita Mitra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2Deborah Goldfrank, Shannon Chuai, Jonine L Bernstein, et al.
BMC Medical Genetics|January 17, 2003
Frequency of CHEK2*1100delC in New York breast cancer cases and controlsKenneth Offit, Heather Pierce, Tomas Kirchhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2021
Facilitated cascade testing (FaCT): a randomized controlled trialRoni Nitecki, Haley A Moss, Catherine H Watson, et al.
Journal of Medical Genetics|March 19, 2011
Germline PALB2 mutation analysis in breast-pancreas cancer familiesZsofia K Stadler, Erin Salo-Mullen, Nelly Sabbaghian, et al.
Journal of the American College of Surgeons|December 24, 2011
Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resectionEmily Steinhagen, Jinru Shia, Arnold J Markowitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 25, 2019
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Amethyst Saldia, Sara H Olson, Pamela Nunes, et al.
BMC Genetics|October 6, 2007
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studiesLutécia H Mateus Pereira, Marbin A Pineda, William H Rowe, et al.
Pageof 43

Showing results (81-90 of 429) with videos related to

Sort By:
Pageof 43
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
JCO Oncology Practice|October 15, 2021
Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 PandemicKelsey E Breen, Malwina Tuman, Corinna E Bertelsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
BRCA mutations and risk of prostate cancer in Ashkenazi JewsTomas Kirchhoff, Noah D Kauff, Nandita Mitra, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2Deborah Goldfrank, Shannon Chuai, Jonine L Bernstein, et al.
BMC Medical Genetics|January 17, 2003
Frequency of CHEK2*1100delC in New York breast cancer cases and controlsKenneth Offit, Heather Pierce, Tomas Kirchhoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2021
Facilitated cascade testing (FaCT): a randomized controlled trialRoni Nitecki, Haley A Moss, Catherine H Watson, et al.
Journal of Medical Genetics|March 19, 2011
Germline PALB2 mutation analysis in breast-pancreas cancer familiesZsofia K Stadler, Erin Salo-Mullen, Nelly Sabbaghian, et al.
Journal of the American College of Surgeons|December 24, 2011
Systematic immunohistochemistry screening for Lynch syndrome in early age-of-onset colorectal cancer patients undergoing surgical resectionEmily Steinhagen, Jinru Shia, Arnold J Markowitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 25, 2019
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Amethyst Saldia, Sara H Olson, Pamela Nunes, et al.
BMC Genetics|October 6, 2007
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studiesLutécia H Mateus Pereira, Marbin A Pineda, William H Rowe, et al.
Pageof 43